Scinovex
article Open AccessTop 1% cited

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy

Neurology · 2010 · Vol. 75(23) · pp. 2087–2096
Robert K. HeatonDavid B. CliffordDonald FranklinSteven Paul WoodsChristopher F. AkeFlorin VaidaRonald J. EllisScott LetendreThomas D. MarcotteJ. Hampton AtkinsonMónica Rivera MindtOfilio VigilMichael TaylorAnn C. CollierChristina M. MarraBenjamin B. GelmanJustin C. McArthurSusan MorgelloDavid M. SimpsonJ. Allen McCutchanIan AbramsonAnthony GamstChristine Fennema‐NotestineTerry L. JerniganJ. WongIgor GrantFor the CHARTER Group

Abstract

The most severe HAND diagnosis (HAD) was rare, but milder forms of impairment remained common, even among those receiving CART who had minimal comorbidities. Future studies should clarify whether early disease events (e.g., profound CD4 decline) may trigger chronic CNS changes, and whether early CART prevents or reverses these changes.

HIV Research and TreatmentHIV-related health complications and treatmentsCytomegalovirus and herpesvirus researchNeurocognitiveMedicineComorbidityCartDementiaInternal medicinePediatricsDiseasePsychiatryCognition

MeSH terms

Activities of Daily LivingAdultAlgorithmsCognition DisordersDisability EvaluationEnzyme-Linked Immunosorbent AssayFemaleHumansMaleMiddle AgedNeurologic ExaminationNeuropsychological TestsPsychiatric Status Rating ScalesRetrospective StudiesModels, Statistical

Funding

  • National Institutes of Health
Citations
2,290
FWCI
35.31
field-weighted impact
References
34
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy · Scinovex